Last year, a 45-year-old woman walked into my screening center in Laurel, MD. She was fit, healthy, and had no symptoms whatsoever. She just wanted peace of mind, the kind of baseline health data that her annual physical could not provide. Ninety minutes later, her whole-body MRI revealed a kidney tumor she did not know existed. No pain. No blood in her urine. Nothing to suggest she was harboring a cancer that, left undiscovered, would have eventually announced itself with far worse news.

When I added preventative screening to my traditional radiology focus, colleagues raised their eyebrows. Some were skeptical. A few were openly critical. The medical establishment has long been wary of screening healthy people, and not without reason. Concern around “overdiagnosis” looms large in medicine. Are we creating anxious patients chasing findings that do not really matter? Or are we finally using our most powerful imaging technology the way it should have been used all along, before symptoms appear?

After reviewing hundreds of whole-body scans, I have come to believe the answer is more nuanced than either camp admits. And it is a conversation we need to have honestly.

Why I made the switch

As a fellowship-trained radiologist specializing in body imaging, I spent years reading diagnostic scans ordered after patients developed symptoms. I saw far too many of those scans come in too late to have an impact. The pancreatic mass already invading surrounding structures. The lung nodule that has grown beyond early intervention. The aortic aneurysm discovered during an emergency rather than a routine screen.

The truth about symptom-based medicine is that symptoms often signal advanced disease. By the time you feel something, biology has already been at work, sometimes for years. When we start to think about symptoms as our trigger for action, it is really quite dangerous, because when those symptoms finally do occur, it is often too late.

Consider the cancers that kill most aggressively: pancreatic, liver, or gastric. A relative of yours could have pancreatic cancer today and then pass within a year; that is how aggressive some of these diseases are. The asymmetry between when these cancers become detectable and when they become symptomatic represents a window of opportunity we have largely ignored.

The incidental finding dilemma

Whole-body MRI (or full-body scan) does face a practical reality: Screening healthy people means finding things. Lots of things. Research suggests that 40 to 50 percent of whole-body MRI screenings identify at least one incidental finding. That number sounds alarming until you understand what it actually means.

Most incidental findings fall into predictable categories. Many are clinically insignificant: normal anatomical variants or benign findings requiring no action. Some warrant surveillance imaging in six to 12 months to ensure stability. A smaller subset requires further evaluation: additional imaging, specialist referral, or occasionally biopsy. And rarely, we find something urgent that demands immediate attention.

But preventive screening critics often miss that the anxiety question cuts both ways. Yes, finding an indeterminate liver lesion creates uncertainty. But you know what creates worse anxiety? Discovering that same lesion three years later when it has grown, metastasized, and transformed from a treatable problem into a terminal diagnosis. The question is not whether uncertainty is uncomfortable. It is whether managed uncertainty today is preferable to catastrophic certainty tomorrow.

What fellowship training actually means

The criticism of the false positive issue does have some grounding in truth. Not everyone reading these scans has equivalent training. A board-certified radiologist has completed residency and passed examinations. That is the minimum. But fellowship training, an additional year of subspecialized study in body imaging, represents a different level of expertise.

Why does this matter? Because distinguishing a concerning finding from an insignificant one often requires pattern recognition developed over thousands of reads. A fellowship-trained MRI radiologist, someone who has completed an additional fellowship devoted specifically to MRI interpretation, learning to read scans of every region of the body from the brain all the way down to the toes, can significantly decrease the false positive rate. This reduces unnecessary follow-up testing, avoids unwarranted anxiety, and spares patients from procedures they did not need. When you are screening healthy people, the interpreter’s skill is what matters. You are not confirming a suspected diagnosis; you are sorting signal from noise in a population where most findings will be nothing.

The four questions no one asks

I tell patients there are four questions they should ask before booking any whole-body MRI scan:

• Is the scan being done appropriately and on a good MRI scanner?
• Who is reading my scan?
• Will I be able to talk to a doctor afterward?
• And what happens if they find something?

That first question deserves particular attention. Full-body MRI requires the latest generation of MRI scanners to perform a truly comprehensive scan within roughly an hour. Many places advertise “full body scans,” but not all of them are performing the MRI sequences that are critical for diagnosing cancer. The best example is full-body diffusion imaging. Diffusion is the single most powerful tool available in MRI for detecting cancer; it measures how water molecules move through tissue, and cancerous cells restrict that movement in ways that light up on the scan like a signal flare.

Yet some imaging centers only perform diffusion scanning for a portion of the body, and others omit it altogether. The absence of diffusion imaging, or improperly performed diffusion imaging, can lead to missed cancers or, paradoxically, increase false positives by forcing radiologists to rely on less definitive sequences. When you are investing in preventive screening, the technology matters as much as the expertise behind it.

The answers matter more than the marketing. Some providers offer automated reports with no physician consultation. Others charge extra for the conversation that should be included. And too few have clear pathways for what comes next when findings require follow-up. At my practice, I personally review every scan and meet with patients to discuss results. That is not a selling point; it is what responsible preventive screening should look like. You should not receive a PDF and be left wondering what it means.

A paradigm shift, not a replacement

A whole-body MRI does not pick up all cancers, and it should not replace your established screening routine. If you are due for a mammogram or a colonoscopy, get them. These are validated, evidence-based tools with decades of population-level data supporting their use.

What whole-body MRI adds is comprehensiveness for areas traditional screening does not address. We are imaging nine different body regions in a single session: brain, face, neck, chest, abdomen, pelvis, and the entire spine. If you wanted that coverage through conventional medicine, you would need to see a neurologist for the brain, a pulmonologist for the chest, a gastroenterologist for the abdomen, and somehow coordinate all of it. That fragmentation is why comprehensive prevention through traditional health care is practically impossible for most patients.

The future we are building

Medicine has always struggled with the tension between doing too much and doing too little. Screening programs can miss disease. They can also find problems that would never have caused harm. Navigating that tension requires both humility about what we do not know and willingness to evolve our practice as evidence accumulates.

What I have learned from hundreds of preventive scans is that the question is not whether to screen; it is how to screen thoughtfully. That means appropriate patient selection: I do not recommend this for everyone, particularly those under 30 where the baseline rate of significant findings is low. It means expert interpretation by fellowship-trained specialists who understand the difference between concerning and benign. And it means ongoing dialogue with patients about what we are finding, what it means, and what comes next.

That 45-year-old woman with the incidentally discovered kidney tumor? She had surgery within weeks. Her prognosis is excellent precisely because we found it early, before it announced itself through symptoms that would have indicated a far more advanced disease. She did not feel sick when she walked into my office. But she was. And now she is not.

That is the future I am trying to build: Medicine that catches disease when it is still controllable, in patients who feel fine but will not feel fine forever. It is not perfect. No screening tool is. But used appropriately, whole-body MRI represents something we have rarely had access to before, a comprehensive window into what is happening inside healthy people, with enough resolution to act on what we find.

The skeptics are not wrong to ask hard questions. But neither are the patients who have started asking a harder question of their own: Why should I wait until I am sick to find out what is wrong?

Amit Newatia is a radiologist.